Pharmacovigilance and Drug Safety
Pharmacovigilance and Drug Safety
Pharmacovigilance refers to the science and activities related to the detection, assessment, understanding, and prevention of adverse drug reactions (ADRs) or any other drug-related problems. The primary goal is to improve patient safety by identifying risks associated with drugs, ensuring that the benefits of medications outweigh the risks, and ultimately optimizing the therapeutic use of drugs. Drug safety is an integral part of pharmacovigilance and is focused on monitoring and managing the safety of drugs throughout their lifecycle, from development to post-market use.
Related Conference of Pharmacovigilance and Drug Safety
Pharmacovigilance and Drug Safety Conference Speakers
Recommended Sessions
- Advanced Drug Delivery Systems
- Advances in Vaccine Technology
- Advances in Omics Technologies
- Artificial Intelligence in Biomedicine
- Biotechnology in Drug Development
- Cardiovascular Pharmacotherapy
- Clinical Pharmacology and Therapeutics
- Digital Health and Telemedicine
- Ethical Challenges and Regulatory Science in Healthcare and Pharmaceuticals
- Gene Therapy and Genetic Medicine
- Immunotherapy and Immunopharmacology
- Infectious Diseases and Antimicrobial Resistance
- Innovations in Biologics and Biosimilars
- Metabolic Disorders and Endocrinology
- Nanotechnology in Biomedicine
- Neuropharmacology and Neurotherapeutics
- Oncology Research and Therapeutics
- Paediatric and Geriatric Pharmacotherapy
- Pharmacogenomics and Personalized Medicine
- Pharmacovigilance and Drug Safety
- Public Health and Pharmacoeconomics
- Rare and Orphan Diseases: Therapeutic Approaches
- Rare Disease Therapeutics
- Regenerative Medicine and Tissue Engineering
- Respiratory and Pulmonary Pharmacotherapy